Stephen Mahoney
Förmögenhet: 630 963 $ per 2026-07-31
Förmögenhet: 630 963 $ per 2026-07-31
Stephen Frank Mahoney was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the title held was President & Chief Operating Officer from 2017 to 2019.
Current jobs include President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. since 2023, and Director at Vesselon, Inc. Former jobs include Attorney at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC; Chief Commercial Officer & Senior Vice President at Synageva BioPharma Corp.
from 2014 to 2015; COO, CFO, Treasurer & Chief Accounting Officer at Magenta Therapeutics, Inc. from 2020 to 2023; Chief Operating & Financial Officer at Dianthus Therapeutics, Inc. from 2020 to 2023; and Attorney at Genzyme Corp.
Education includes undergraduate studies at The Colorado College, graduate studies at Boston College Law School, and an MBA from Wallace E Carroll School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 33 349 ( 0,03 % ) | 630 963 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Verkställande Direktör | 2023-10-30 |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Finansdirektör/CFO | 2023-09-01 |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Grundare | 2019-11-15 |
| SYNAGEVA BIOPHARMA CORP | Företagsledare/Principal | 2015-01-01 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
| MAGENTA THERAPEUTICS | Finansdirektör/CFO | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The Colorado College
The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån